1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MGMT immunohistochemistry (IHC) and exclusion of pancreatic NET (PanNET) patients from treatment with temozolomide-based therapy
    Meeting Abstract

    Reidy, D. L.; Basturk, O.; Kriplani, A.; Abou-Alfa, G. K.; Jarnagin, W. R.; Allen, P. J.; Saltz, L.; Klimstra, D. S.; Zhang, L. Y.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I trial of the hedgehog (Hh) inhibitor, LDE225, in combination with etoposide and cisplatin (EP) for initial treatment of extensive stage small cell lung cancer (ES-SCLC)
    Meeting Abstract

    Pietanza, M. C.; Krug, L. M.; Varghese, A. M.; Fleisher, M.; Teitcher, J. B.; Holodny, A.; Sima, C. S.; Litvak, A. M.; Ng, K. K.; Patel, P. R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Outcomes of biliary stents in advanced pancreatic cancer in the era of improved systemic therapy
    Meeting Abstract

    Park, W.; Mankal, P. K.; O'Reilly, E. M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Multiplatform molecular profiling of 2,400 pancreatic adenocarcinomas to identify targets for therapeutic intent
    Meeting Abstract

    Millis, S. Z.; Arguello, D.; Lowery, M. A.; O'Reilly, E. M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 1 study of MEDI4736, an anti PD-L1 antibody, in patients with advanced solid tumors
    Meeting Abstract

    Lutzky, J.; Antonia, S. J.; Blake-Haskins, A.; Li, X.; Robbins, P. B.; Shaiabl, A. M.; Vasseill, J.; Ibrahim, R. A.; Khleif, S.; Segal, N. H.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Evaluation of PARP inhibition as a platinum sparing strategy in BRCA2-deficient pancreatic tumors
    Meeting Abstract

    Lowery, M. A.; Lee, A.; Tobias, E.; Sung, P.; Bhanot, U.; Shakya, R.; Ludwig, T.; O'Reilly, E. M.; Jasin, M.; Moynahan, M. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Treatment, outcomes, and clinical trial participation in very elderly patients (pts) with metastatic pancreas cancer (mPC)
    Meeting Abstract

    Li, D.; Capanu, M.; Yu, K. H.; Lowery, M. A.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Standardized radiofrequency ablation (sRFA) >= 45 minutes (m) plus lyso-thermosensitive liposomal doxornbicin (LTLD) for solitary hepatocellular carcinoma (HCC) lesions 3-7 cm: A retrospective analysis of phase III HEAT study
    Meeting Abstract

    Lencioni, R.; Tak, W. Y.; Chen, M. H.; Finn, R. S.; Sherman, M.; Makrls, L.; O'Neal, M.; Slmonlch, W.; Haemmerlch, D.; Reed, R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Patient-derived xenografts as models for the identification of predictive biomarkers in esophagogastric cancer
    Meeting Abstract

    Janjigian, Y. Y.; Vakiani, E.; Imtiaz, T.; Huang, X.; Ilson, D. H.; Rizk, N. P.; Coit, D. G.; Strong, V. E.; de Stanchina, E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save